CA2934078C - Extruded extended release abuse deterrent pill - Google Patents
Extruded extended release abuse deterrent pill Download PDFInfo
- Publication number
- CA2934078C CA2934078C CA2934078A CA2934078A CA2934078C CA 2934078 C CA2934078 C CA 2934078C CA 2934078 A CA2934078 A CA 2934078A CA 2934078 A CA2934078 A CA 2934078A CA 2934078 C CA2934078 C CA 2934078C
- Authority
- CA
- Canada
- Prior art keywords
- extended release
- formulation
- oral
- abuse deterrent
- abuse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361917074P | 2013-12-17 | 2013-12-17 | |
US201361917120P | 2013-12-17 | 2013-12-17 | |
US61/917,120 | 2013-12-17 | ||
US61/917,074 | 2013-12-17 | ||
US201461980254P | 2014-04-16 | 2014-04-16 | |
US201461980259P | 2014-04-16 | 2014-04-16 | |
US61/980,254 | 2014-04-16 | ||
US61/980,259 | 2014-04-16 | ||
US14/457,714 US10195153B2 (en) | 2013-08-12 | 2014-08-12 | Extruded immediate release abuse deterrent pill |
US14/457,714 | 2014-08-12 | ||
PCT/US2014/070942 WO2015095387A1 (en) | 2013-12-17 | 2014-12-17 | Extruded extended release abuse deterrent pill |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2934078A1 CA2934078A1 (en) | 2015-06-25 |
CA2934078C true CA2934078C (en) | 2019-08-06 |
Family
ID=53403652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2934078A Expired - Fee Related CA2934078C (en) | 2013-12-17 | 2014-12-17 | Extruded extended release abuse deterrent pill |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3082775A4 (de) |
JP (2) | JP6403780B2 (de) |
AU (3) | AU2014364800A1 (de) |
CA (1) | CA2934078C (de) |
WO (1) | WO2015095387A1 (de) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2325046T3 (es) * | 1996-06-26 | 2009-08-24 | The Board Of Regents, The University Of Texas System | Formulacion farmaceutica extruible por fusion en caliente. |
CA2572491A1 (en) * | 2004-07-01 | 2006-01-12 | Gruenenthal Gmbh | Oral dosage form safeguarded against abuse |
US20080152595A1 (en) * | 2004-11-24 | 2008-06-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
DE102007011485A1 (de) * | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
GB0909680D0 (en) * | 2009-06-05 | 2009-07-22 | Euro Celtique Sa | Dosage form |
EA201400172A1 (ru) * | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
JP6103785B2 (ja) * | 2012-04-18 | 2017-03-29 | マリンクロッド エルエルシー | 乱用抑止特性を有する即放性医薬組成物 |
KR20150059167A (ko) * | 2012-07-06 | 2015-05-29 | 에갈렛 리미티드 | 제어된 방출을 위한 남용 제지 약학적 조성물 |
CA3042642A1 (en) * | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
-
2014
- 2014-12-17 CA CA2934078A patent/CA2934078C/en not_active Expired - Fee Related
- 2014-12-17 EP EP14871095.7A patent/EP3082775A4/de not_active Withdrawn
- 2014-12-17 WO PCT/US2014/070942 patent/WO2015095387A1/en active Application Filing
- 2014-12-17 AU AU2014364800A patent/AU2014364800A1/en not_active Abandoned
- 2014-12-17 JP JP2016540580A patent/JP6403780B2/ja not_active Expired - Fee Related
-
2018
- 2018-09-11 JP JP2018169278A patent/JP6678212B2/ja not_active Expired - Fee Related
- 2018-10-25 AU AU2018253567A patent/AU2018253567B2/en not_active Ceased
-
2019
- 2019-08-16 AU AU2019216710A patent/AU2019216710A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP6678212B2 (ja) | 2020-04-08 |
JP2017503780A (ja) | 2017-02-02 |
AU2018253567A1 (en) | 2018-11-08 |
EP3082775A4 (de) | 2017-05-17 |
WO2015095387A1 (en) | 2015-06-25 |
AU2014364800A1 (en) | 2016-07-07 |
JP2019001816A (ja) | 2019-01-10 |
EP3082775A1 (de) | 2016-10-26 |
AU2019216710A1 (en) | 2019-09-12 |
JP6403780B2 (ja) | 2018-10-10 |
CA2934078A1 (en) | 2015-06-25 |
AU2018253567B2 (en) | 2019-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10639281B2 (en) | Extruded immediate release abuse deterrent pill | |
US10792254B2 (en) | Extruded extended release abuse deterrent pill | |
US20160199369A1 (en) | Extruded Immediate Release Abuse Deterrent Pill | |
AU2018253567B2 (en) | Extruded extended release abuse deterrent pill | |
EP3032948B1 (de) | Extrudierte missbrauchssichere pille mit sofortiger freisetzung | |
US10172797B2 (en) | Extruded extended release abuse deterrent pill | |
EP3169315B1 (de) | Missbrauchssichere flüssigkeitsfülldosierform mit unmittelbarer freisetzung | |
CA3078272A1 (en) | Modified release abuse deterrent dosage forms | |
EP3209282A1 (de) | Missbrauchssichere flüssigkeitsfülldosierform mit verlängerter freisetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20170227 |
|
MKLA | Lapsed |
Effective date: 20201217 |